Inventor
HAN XIAOJUN
US23 patents
⚠️ This page may combine multiple inventors who share the name “HAN XIAOJUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
16 patentsUS7834007B2Nov 16, 2010
CGRP antagonists
BRISTOL MYERS SQUIBB CO9 citations84
US7842808B2Nov 30, 2010
Anti-migraine spirocycles
BRISTOL MYERS SQUIBB CO13 citations83
US7772244B2Aug 10, 2010
Therapeutic agents for the treatment of migraine
BRISTOL MYERS SQUIBB CO12 citations83
US7314883B2Jan 1, 2008
Anti-migraine treatments
BRISTOL MYERS SQUIBB CO12 citations83
US10266578B2Apr 23, 2019
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
BRISTOL MYERS SQUIBB CO9 citations82
US7220862B2May 22, 2007
Calcitonin gene related peptide receptor antagonists
BRISTOL MYERS SQUIBB CO11 citations81
US7244746B2Jul 17, 2007
Imidazolyl derivatives as corticotropin releasing factor inhibitors
BRISTOL MYERS SQUIBB CO9 citations74
US10968219B2Apr 6, 2021
3-substituted propionic acids as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO2 citations68
US7125990B2Oct 24, 2006
Imidazolyl derivatives as corticotropin releasing factor inhibitors
BRISTOL MYERS SQUIBB CO3 citations63
US12097242B2Sep 24, 2024
Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides
BRISTOL MYERS SQUIBB CO0 citations61
US12097241B2Sep 24, 2024
Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides
BRISTOL MYERS SQUIBB CO0 citations61
US11364281B2Jun 21, 2022
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
BRISTOL MYERS SQUIBB CO0 citations61
US11185570B2Nov 30, 2021
Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides
BRISTOL MYERS SQUIBB CO0 citations61
US7449586B2Nov 11, 2008
Processes for the preparation of CGRP-receptor antagonists and intermediates thereof
BRISTOL MYERS SQUIBB CO4 citations61
US11884661B2Jan 30, 2024
3-substituted propionic acids as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US7470680B2Dec 30, 2008
Constrained compounds as CGRP-receptor antagonists
BRISTOL MYERS SQUIBB CO1 citations51
IMMUNOME INC
6 patentsUS12186403B2Jan 7, 2025
Immunoconjugates and methods
IMMUNOME INC1 citations72
US12285492B2Apr 29, 2025
Immunoconjugates and methods
IMMUNOME INC0 citations60
US12280121B2Apr 22, 2025
Immunoconjugates and methods
IMMUNOME INC0 citations60
US12274754B2Apr 15, 2025
Immunoconjugates and methods
IMMUNOME INC0 citations60
US12268750B2Apr 8, 2025
Immunoconjugates and methods
IMMUNOME INC0 citations60
US12545716B2Feb 10, 2026
Immunoconjugates and methods
IMMUNOME INC0 citations50